Catherine Bollard

Catherine Bollard

Company: Children’s National Medical Center

Job title: Director, Center for Cancer & Immunology


Using T cell Therapies Targeting Latent EBV Proteins for Lymphoma Treatment 4:00 pm

• Understanding the differences between antigen specific T cells and CAR T cells • To appreciate the challenges of targeting EBV Type II latency tumors versus type III latency • Understand how lessons learned from EBV-specific T cells are being used to target other viruses such as HIV, HPV and SARS-CoV2Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.